Cardiac arrhythmias associated with immune checkpoint inhibitors: A comprehensive disproportionality analysis of the FDA adverse event reporting system

Introduction: With the widespread application of Immune checkpoint inhibitors (ICIs), it is important to explore the association between ICIs and cardiac arrhythmias and to characterize the clinical features of ICI-associated cardiac arrhythmias in real-world studies. Objective: The purpose of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Feifei, Wei, Qi, Wu, Xinan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672082/
https://www.ncbi.nlm.nih.gov/pubmed/36408225
http://dx.doi.org/10.3389/fphar.2022.986357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672082/
https://www.ncbi.nlm.nih.gov/pubmed/36408225
http://dx.doi.org/10.3389/fphar.2022.986357

Ejemplares similares